Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
95.8M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
-1.57M
-
Total reported value, excl. options
-
$26.9M
-
Value change
-
-$3.48M
-
Put/Call ratio
-
15.43
-
Number of buys
-
18
-
Number of sells
-
-28
-
Price
-
$1.47
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q3 2023
68 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q3 2023.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
of 95.8M outstanding shares and own 19.07% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.34M shares), Omega Fund Management, LLC (1.79M shares), Gratus Capital LLC (1.69M shares), VANGUARD GROUP INC (1.66M shares), BVF INC/IL (1.15M shares), UBS OCONNOR LLC (762K shares), ACADIAN ASSET MANAGEMENT LLC (757K shares), RENAISSANCE TECHNOLOGIES LLC (577K shares), Parkman Healthcare Partners LLC (563K shares), and Ikarian Capital, LLC (450K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.